Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 14.5313.9611.0922.7930.42

What is the latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BAFNA PHARMACEUTICALS is 14.53 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202514.53
Mar202413.96
Mar202311.09
Mar202222.79
Mar202130.42

How is EV/Core EBITDA of BAFNA PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 14.53
4.08
Mar2024 13.96
25.88
Mar2023 11.09
-51.34
Mar2022 22.79
-25.08
Mar2021 30.42 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹613.4 Cr 6.8% 18.3% 241% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,408.0 Cr 1.8% 6.8% 17.8% Stock Analytics
DIVIS LABORATORIES ₹206,906.0 Cr 6.7% 18.5% 12.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,521.0 Cr -3.7% 5.5% 39.8% Stock Analytics
CIPLA ₹119,032.0 Cr 5.7% 0.6% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.1 Cr -2% -15.8% -8.4% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

6.8%

18.3%

241%

SENSEX

1.2%

1.2%

-5.5%


You may also like the below Video Courses